| 常用名 | Toceranib-d8 | CAS号 | 1795134-78-9 |
|---|---|---|---|
| 价格 | 纯度 | 95.0% | |
| 备货期 | 10天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: Toceranib-d8 (SU11654-d8) is the deuterium labeled Toceranib. Toceranib (SU11654) is an orally active receptor tyrosine kinase (RTK) inhibitor, and it potently inhibits PDGFR, VEGFR, and Kit with Kis of 5 and 6 nM for PDGFRβ and Flk-1/KDR, respectively. Toceranib (SU11654) has antitumor and antiangiogenic activity, and used in the treatment of canine mast cell tumors[1][2]. 物理化学性质: CAS号:1795134-78-9 常用中文名:Toceranib-d8 常用英文名:Toceranib-d8 分子式:C22H17D8FN4O2 分子量:404.51 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A 储存条件:2-8°C,干燥,密封 |